The vaccine, called rVSV-ZEBOV, has been tested on more than 4,000 people who had been in close contact with someone with Ebola.
In the journal The Lancet, where the trial results were published, the authors called the vaccine “highly efficacious and safe in preventing Ebola virus disease.”
More articles on Ebola:
How to prepare for a major public health event: 5 tips from 4 Chicago hospitals
Most healthcare workers improperly remove protective equipment
Researchers develop aerosolized Ebola vaccine: 3 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
